Expensify, Inc.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
EXFY$1.72-7.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Changes in Stockholders’ Equity
| Preferred stock · Common stock · Additional paid-in capital · Accumulated deficit · Total stockholders' equity | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount | |||||||
| Balance at June 30, 2026 | — | $— | 91,897,067 | $9 | $312,958 | $(178,405) | $134,562 |
| Issuance of common stock upon exercise of stock options | — | — | 23,337 | — | 27 | — | 27 |
| Issuance of restricted stock units | — | — | 3,731 | — | 5 | — | 5 |
| Settlement of liability-classified restricted common shares | — | — | 144,311 | — | — | — | — |
| Issuance of common stock under the Matching Plan | — | — | 911,994 | — | 927 | — | 927 |
| Issuance of common stock in connection with restricted stock units vesting | — | — | 178,962 | — | — | — | — |
| Shares withheld from common stock issued to pay employee payroll taxes | — | — | (56,852) | — | (133) | — | (133) |
| Repurchase and retirement of common stock | — | — | (722,121) | — | (1,265) | — | (1,265) |
| Stock-based compensation | — | — | — | — | 6,673 | — | 6,673 |
| Net loss | — | — | — | — | — | (3,335) | (3,335) |
| Balance at September 30, 2026 | — | $— | 92,380,429 | $9 | $319,192 | $(181,740) | $137,461 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
| Preferred stock · Common stock · Additional paid-in capital · Accumulated deficit · Total stockholders' equity | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount | |||||||
| Balance at June 30, 2025 | — | $— | 92,647,210 | $9 | $294,591 | $(162,785) | $131,815 |
| Issuance of common stock upon exercise of stock options | — | — | 260,962 | — | 198 | — | 198 |
| Issuance of restricted stock units | — | — | 2,128 | — | 5 | — | 5 |
| Settlement of liability-classified restricted common shares | — | — | 237,573 | — | — | — | — |
| Issuance of common stock under the Matching Plan | — | — | 1,267,158 | — | 1,741 | — | 1,741 |
| Issuance of common stock in connection with restricted stock units vesting | — | — | 196,268 | — | — | — | — |
| Repurchase and retirement of common stock | — | — | (1,579,763) | — | (3,031) | — | (3,031) |
| Stock-based compensation | — | — | — | — | 7,247 | — | 7,247 |
| Net loss | — | — | — | — | — | (2,315) | (2,315) |
| Balance at September 30, 2025 | — | $— | 93,031,536 | $9 | $300,751 | $(165,100) | $135,660 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
| Preferred stock · Common stock · Additional paid-in capital · Accumulated deficit · Total stockholders' equity | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount | |||||||
| Balance at December 31, 2025 | — | $— | 93,060,902 | $9 | $304,953 | $(172,217) | $132,745 |
| Issuance of common stock upon exercise of stock options | — | — | 67,408 | — | 66 | — | 66 |
| Issuance of restricted stock units | — | — | 12,375 | — | 15 | — | 15 |
| Settlement of liability-classified restricted common shares | — | — | 872,900 | — | — | — | — |
| Issuance of common stock under the Matching Plan | — | — | 5,215,027 | 1 | 4,209 | — | 4,210 |
| Issuance of common stock in connection with restricted stock units vesting | — | — | 695,830 | — | — | — | — |
| Shares withheld from common stock issued to pay employee payroll taxes | — | — | (56,852) | — | (133) | — | (133) |
| Repurchase and retirement of common stock | — | — | (7,487,161) | (1) | (10,489) | — | (10,490) |
| Stock-based compensation | — | — | — | — | 20,571 | — | 20,571 |
| Net loss | — | — | — | — | — | (9,523) | (9,523) |
| Balance at September 30, 2026 | — | $— | 92,380,429 | $9 | $319,192 | $(181,740) | $137,461 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
| Preferred stock · Common stock · Additional paid-in capital · Accumulated deficit · Total stockholders' equity | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount | |||||||
| Balance at December 31, 2024 | — | $— | 91,376,765 | $9 | $279,062 | $(150,828) | $128,243 |
| Issuance of common stock upon exercise of stock options | — | — | 357,044 | — | 315 | — | 315 |
| Vesting of early exercised stock options | — | — | — | — | 113 | — | 113 |
| Issuance of restricted stock units | — | — | 8,600 | — | 28 | — | 28 |
| Settlement of liability-classified restricted common shares | — | — | 382,393 | — | — | — | — |
| Issuance of common stock under the Matching Plan | — | — | 2,950,902 | — | 4,351 | — | 4,351 |
| Issuance of common stock in connection with restricted stock units vesting | — | — | 820,931 | — | — | — | — |
| Repurchase and retirement of common stock | — | — | (2,865,099) | — | (6,057) | — | (6,057) |
| Stock-based compensation | — | — | — | — | 22,939 | — | 22,939 |
| Net loss | — | — | — | — | — | (14,272) | (14,272) |
| Balance at September 30, 2025 | — | $— | 93,031,536 | $9 | $300,751 | $(165,100) | $135,660 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.